Sign in Sign up for free

Theratechnologies EPS Q/Q

What is the EPS Q/Q of Theratechnologies?

The EPS Q/Q of Theratechnologies, Inc. is -15.38%

What is the definition of EPS Q/Q?



Quarterly EPS growth rate, year over year, is the increase of the company’s EPS for the most recent quarter compared to the the same quarter in the previous year.

quarterly growth yoy (year over year)

The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

EPS Q/Q of companies in the Health Care sector on TSX compared to Theratechnologies

What does Theratechnologies do?

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Companies with eps q/q similar to Theratechnologies